ID: ALA5202438

Max Phase: Preclinical

Molecular Formula: C30H42N8O3

Molecular Weight: 562.72

Associated Items:

Representations

Canonical SMILES:  CC(C)N(C[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)C1CC(CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1

Standard InChI:  InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17?,19?,22-,25-,26-,29-/m0/s1

Standard InChI Key:  LXFOLMYKSYSZQS-JMYAXFFQSA-N

Associated Targets(Human)

Histone-lysine N-methyltransferase, H3 lysine-79 specific 648 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 562.72Molecular Weight (Monoisotopic): 562.3380AlogP: 3.32#Rotatable Bonds: 8
Polar Surface Area: 151.23Molecular Species: BASEHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.28CX Basic pKa: 9.05CX LogP: 3.31CX LogD: 1.61
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: -0.18

References

1. Talukdar A, Mukherjee A, Bhattacharya D..  (2022)  Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.,  65  (3.0): [PMID:35014841] [10.1021/acs.jmedchem.1c01208]

Source